Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Effects of Dabigatran and Rivaroxaban On Routine and Specialized Coagulation Assays: A Study Using Actual Patient Plasma Samples

Tyler W. Smith, MD, FRCPC, Leslie Zypchen, MD, FRCPC, Cedric J. Carter, MD, FRCPC, Annie Tran, Pamela Colley, NP, Kenneth Gin, MD, FRCPC, Philip Teal, MD, FRCPC, Bassam A. Masri, MD, FRCSC, Agnes Y.Y. Lee, MD, MSc, FRCPC

Blood (2012) 120 (21): 23.

https://doi.org/10.1182/blood.V120.21.23.23

Published: 2012

Journal Articles

High Dose Melphalan and Autologous Stem Cell Transplantation In Light Chain and Light and Heavy Chain Deposition Disease: Hematologic and Renal Outcomes.

David Telio, MD, John Shepherd, Donna L. Forrest, MD, Michael J. Barnett, BMBS, Thomas J. Nevill, MD, FRCPC, Leslie Zypchen, MD, Kevin Song, MD

Blood (2010) 116 (21): 4597.

https://doi.org/10.1182/blood.V116.21.4597.4597

Published: 2010

Journal Articles

Diagnosis and Treatment of Essential Thrombocythemia: Assessment of Current Clinical Practice.

Vivian H Y Lee, BSc, Erica Peterson, M.Sc., M.D., Leslie Zypchen, MD, Lynda M Foltz, MD

Blood (2009) 114 (22): 1903.

https://doi.org/10.1182/blood.V114.22.1903.1903

Published: 2009

Journal Articles

Thrombotic Complications and Risk of Myeloid Transformation in 164 Elderly Patients with Essential Thrombocythemia.

Erica Peterson, M.Sc., M.D., Leslie Zypchen, MD, Janet Nitta, Jonathan Berkowitz, M.Sc., Ph.D., Lynda M Foltz, MD

Blood (2009) 114 (22): 2916.

https://doi.org/10.1182/blood.V114.22.2916.2916

Published: 2009

Journal Articles

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Hatoon Ezzat, MD, Douglas Filipinko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio S.G. Montaner, MD, Marianne Harris, MD, Robert S. Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2006) 108 (11): 4666.

https://doi.org/10.1182/blood.V108.11.4666.4666

Published: 2006

Journal Articles

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

Hatoon Ezzat, MD, Jonathan C. Wong, BHSc, Douglas Filipenko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio S.G. Montaner, MD, Marianne Harris, MD, Robert S. Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2006) 108 (11): 4667.

https://doi.org/10.1182/blood.V108.11.4667.4667

Published: 2006

Journal Articles

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Hatoon Ezzat, MD, J. Doug Filipenko, MD, Linda M. Vickars, MD, Paul F. Galbraith, MD, Charles H. Li, MD, Kevin Murphy, MD, Julio Montaner, MD, Marianne Harris, MD, Robert Hogg, MD, Suzanne Vercauteren, MD, Chantal S. Leger, MD, Leslie Zypchen, MD, Heather A. Leitch, MD, PhD

Blood (2005) 106 (11): 4674.

https://doi.org/10.1182/blood.V106.11.4674.4674

Published: 2005

NARROW

Effects of Dabigatran and Rivaroxaban On Routine and Specialized Coagulation Assays: A Study Using Actual Patient Plasma Samples

High Dose Melphalan and Autologous Stem Cell Transplantation In Light Chain and Light and Heavy Chain Deposition Disease: Hematologic and Renal Outcomes.

Diagnosis and Treatment of Essential Thrombocythemia: Assessment of Current Clinical Practice.

Thrombotic Complications and Risk of Myeloid Transformation in 164 Elderly Patients with Essential Thrombocythemia.

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Effects of Dabigatran and Rivaroxaban On Routine and Specialized Coagulation Assays: A Study Using Actual Patient Plasma Samples

High Dose Melphalan and Autologous Stem Cell Transplantation In Light Chain and Light and Heavy Chain Deposition Disease: Hematologic and Renal Outcomes.

Diagnosis and Treatment of Essential Thrombocythemia: Assessment of Current Clinical Practice.

Thrombotic Complications and Risk of Myeloid Transformation in 164 Elderly Patients with Essential Thrombocythemia.

Improved Survival of Patients with HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Expressing the Epstein-Barr Virus (EBV) in Malignant Cells Provided Patients Received HAART with Lymphoma Therapy.

Improvement in Outcome of Patients with CD30+ HIV-Related Systemic B-Cell Non-Hodgkin’s Lymphoma (NHL) Providing HIV Infection Is Adequately Controlled.

BCL-2 Expression May Adversely Affect Outcome in HIV-Associated Systemic Diffuse Large B Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only